Literature DB >> 33554588

Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients.

Julien Favresse1,2, Marc Elsen1, Christine Eucher1, Kim Laffineur1, Sandrine Van Eeckhoudt3, Jean-Baptiste Nicolas3, Constant Gillot2, Jean-Michel Dogné2, Jonathan Douxfils2,4.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; antibody; kinetics; long-term

Year:  2020        PMID： 33554588     DOI： 10.1515/cclm-2020-1736

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  5 in total

1.  Assay dependence of long-term kinetics of SARS-CoV-2 antibodies.

Authors:  Anneleen Schallier; Sarah De Baets; Dirk De Bruyne; Kenny Dauwe; Margaux Herpol; Pedro Couck
Journal:  Diagn Microbiol Infect Dis       Date:  2021-04-22       Impact factor: 2.803

2.  Detecting Waning Serological Response with Commercial Immunoassays: 18-Month Longitudinal Follow-up of Anti-SARS-CoV-2 Nucleocapsid Antibodies.

Authors:  Yu Nakagama; Yuko Komase; Natsuko Kaku; Yuko Nitahara; Evariste Tshibangu-Kabamba; Tomoyo Tominaga; Hiroko Tanaka; Tomoaki Yokoya; Minako Hosokawa; Yasutoshi Kido
Journal:  Microbiol Spectr       Date:  2022-07-14

3.  Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa.

Authors:  Kaiyuan Sun; Stefano Tempia; Jackie Kleynhans; Anne von Gottberg; Meredith L McMorrow; Nicole Wolter; Jinal N Bhiman; Jocelyn Moyes; Maimuna Carrim; Neil A Martinson; Kathleen Kahn; Limakatso Lebina; Jacques D du Toit; Thulisa Mkhencele; Cécile Viboud; Cheryl Cohen
Journal:  medRxiv       Date:  2022-08-22

4.  Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection.

Authors:  Julien Favresse; Christine Eucher; Marc Elsen; Constant Gillot; Sandrine Van Eeckhoudt; Jean-Michel Dogné; Jonathan Douxfils
Journal:  Microorganisms       Date:  2021-03-08

5.  Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2.

Authors:  Julien Favresse; Constant Gillot; Laura Di Chiaro; Christine Eucher; Marc Elsen; Sandrine Van Eeckhoudt; Clara David; Laure Morimont; Jean-Michel Dogné; Jonathan Douxfils
Journal:  Viruses       Date:  2021-07-14       Impact factor: 5.048
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.